Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Nifedipine may help treat perniosis, improving symptoms and clearing lesions for some patients.

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Methotrexate may help stabilize frontal fibrosing alopecia.

The research developed new fortilin protein constructs for potential heart disease treatments.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Minoxidil, finasteride, and dutasteride are treatments for hair loss.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Baricitinib may effectively treat lichen planopilaris.

Baricitinib is the most effective treatment for alopecia areata.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.